Compare ALLO & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | PSNYW |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 501.1M |
| IPO Year | 2018 | 2021 |
| Metric | ALLO | PSNYW |
|---|---|---|
| Price | $0.76 | $2.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 11.2M | 30.3K |
| Earning Date | 11-05-2026 | 03-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $72.02 | $79.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.74 | $0.20 |
| 52 Week High | $4.46 | $9.08 |
| Indicator | ALLO | PSNYW |
|---|---|---|
| Relative Strength Index (RSI) | 21.26 | 41.13 |
| Support Level | N/A | $2.88 |
| Resistance Level | $2.25 | $3.45 |
| Average True Range (ATR) | 0.10 | 0.34 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 0.42 | 10.85 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.